AbCellera to present Phase 2 data for ABCL635 at IMS Menopause Congress
AbCellera (Nasdaq: ABCL) said it will give an upcoming oral presentation of Phase 2 data on ABCL635 at the International Menopause Society (IMS) 20th World Congress on Menopause, Sept. 30–Oct. 3, 2026 in Rio de Janeiro, Brazil.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.